Essays on commercial strategy, brand, and growth — drawn from 30 years across pharma, FMCG, biometrics, and B2B technology in the GCC, MEA, and Latin America.
Despite aggressive budgets and stunning launches, many GCC brands fail to gain traction. The failure is rarely the product — it's commercial execution.
The recurring panic of the past year has been the wrong question. AI won't take your job — but it will expose teams without commercial discipline.
Despite heavy investment and broad adoption, omnichannel strategy frequently falters across the GCC and MEA healthcare landscape. Here's why.
Most brand strategies don't fail because they're bad ideas. They fail because they never make it off the PowerPoint slide and into the market.
In B2B healthcare and pharma, are you merely generating leads — or engineering a market that consistently prefers your brand?
Many businesses are busy with marketing — but are they actually growing? Confusing activity with growth wastes resources and stalls results.
A 30-minute strategy diagnostic. No pitch. We'll find where preference is breaking down.
Book a Strategy Diagnostic